DepartmentContent - AIIMS Bhuneshwar

About the Department/Division:

The Department of Radiotherapy was founded by joining ofDr. Dillip K. Paridaas Professor & Head andDr. Saroj K. Das Majumdaras Assistant Professor in April 2013. The Department initiated its clinical activity in form of Day Care service from June 2013 which was inaugurated by Mr. Kesav Desi Raju, the then Secretary of Health & FW, GoI. Subsequently the department started adding more and more services to cancer patients in form of Chemotherapy, Pain, Palliation and other support services. High Energy Linear Accelerator, High Dose Rate Brachytherapy and CT Simulator machines were installed and commissioned in 2018 following which the spectrum of services provided by the department has become complete. The LINAC facility was opened by Shri Dharmendra Pradhan, Hon’ble Union Minister Petroleum. At present the department provides services in form of OPD, IPD, Day Care, External Beam Radiotherapy & Brachytherapy. All patients receive Conformal Radiotherapy. The department provides high precision radiotherapy procedures like Stereotactic Radiosurgery & Radiotherapy, Stereotactic Body Radiotherapy, Image guided Radiotherapy. The department also performs interstitial brachytherapy.Dr. Sandip Kumar Barik joined the department as Assistant Professor in 2020.Shri Sasank Sekhar Beura, Bijay Kumar Barik and Dillip Kumar Sahoojoined as Medical Physicist in 2017 and 2020 respectively. From five persons who started the department in 2013, now grown to 52 persons in 2021. Every day 80-120 patients attend OPD, 45 patients receive treatment from Day Care, 65 patients receive radiation treatment and 15 patients receive IPD services. Every year the department provide services to more than 20,000 patients. The department has started Hospital Based Cancer Registry Program (HBCR) since 2017.

Department Activity Report 2020-21:

MONTH	OLD OPD Case	New OPD Case	IPD	TOTAL DAYCARE CASE -------------------------------------------- CT SC BT				TOTAL HELA FRACTIONS	TOTAL Brachy FRACTIONS	TOTAL Simulation	REMARKS
Apr 2020	555	102	19	372	339	23	10	573	11	26	Due to COVID related travel and other restriction, there was a drop of OPD and IPD number of patients. But number of radiotherapy fractions delivered remained almost unchanged
May 2020	886	227	47	396	327	45	24	692	12	53
June2020	1487	315	73	437	354	68	15	906	12	56
July 2020	838	131	25	477	432	29	16	647	01	48
Aug 2020	702	95	42	379	351	13	15	684	06	40
Sep 2020	822	154	26	333	257	54	22	706	12	52
Oct 2020	867	181	63	349	326	14	09	698	16	71
Nov 2020	1032	260	68	829	764	39	26	921	19	65
Dec 2020	1340	341	78	534	446	70	18	1191	13	87
Jan 2021	1381	318	105	632	523	90	19	1178	12	61
Feb 2021	1632	317	102	690	599	65	26	1114	20	64
Mar 2021	1612	390	110	779	659	110	10	1114	25	64
TOTAL	13154	2831	758	6207				10424	159	687	34,220

Besides regular patient activity, the department also provides advice on Genetic Cancers (Familial Cancer Registry) and also undertakes patient Awareness ProgramCancer Education and Learning (CEAL)

The department has started a strong academic program. Besides MD teaching program, the department provides Internship Program for Medical Physicist, Post-Doctoral Fellowship program in Palliative Medicine, Medical Technology course in Radiotherapy and radiodiagnosis. In addition, the department participates in Undergraduate study program. BSc and MSc Nursing students come to the department for completion of their academic curricula.

The department from time to time collaborate with prestigious Institutes of National Importance like AIIMS, Delhi, JNU, Delhi, IIT, Bhubaneswar, ILS, Bhubaneswar and carry out various Research Projects.

Message from Head of the Department/Division:

The department of Radiotherapy believes in working as a team, started its journey from April 2013 as an infant and has grown to a fully functional young adult in 2021 with all its divisions becoming fully functional. We believe in providing Quality treatment to cancer patients than Quantity. In spite of having one radiation machine, the department provides service to 40-45 patients in form of day care and 60-65 patients treated byConformal form of Radiotherapy. Very soon the department is going to add a second radiation machine in form of High Energy Linear Accelerator and after that the quantity of patients can also be improved further. We treat all our patients with all forms of Conformal Radiotherapy.

Besides clinical activity the department has established a strong academic program. For Post Graduate Teaching Program, we are having a consolidated departmental treatment protocol which integrates further with the PG curriculum. The students from Undergraduate, BSc. & MSc Nursing also get their teaching and training from the department. In order to produce quality trained manpower, the department has started Medical Technology Course in Radiotherapy (MTRT) and internship program for Medical Physicist.

I keep my vision to make this department grow in line of a Centre of Excellence and establish this department as a research hub and regional training centre in various sub-areas of radiotherapy.

Major Achievements:

Installation & Commissioning of High Energy Linear Accelerator
Installation & Commissioning of High Dose Rate Brachytherapy
Initiation of MD (Radiotherapy), PDF (palliative Medicine), MTRT & Internship Program for Medical Physicists

Faculty/Staff

Sl No	Name	Designation	Department	Email	Action
1	Dr. Dillip Kumar Parida	Professor & HOD	Radiotherapy	Rather_dilip@aiimsbhubaneswar.edu.in	View
2	Dr. Saroj Kumar Das Majumdar	Additional Professor	Radiotherapy	rather_saroj@aiimsbhubaneswar.edu.in	View
3	Dr. Sandip Kumar Barik	Assistant Professor	Radiotherapy	radther_sandip@aiimsbhubaneswar.edu.in	View
4	Dr Deepak Kumar Das	Associate Professor	Radiotherapy	radther_deepak@aiimsbhubaneswar.edu.in	View

Medical Physicist Team

Sasank Sekhar Beura Joined: 2016	Bijay Kumar Barik Joined: 2020	Dillip Kumar Sahoo Joined: 2021

CURRICULUM VITAE


Name	:	Prof. Dilip Kumar Parida
Designation	:	Prof & Head
Department Affiliation	:	Radiotherapy
E-mail ID	:	radther_dilip@aiimsbhubaneswar.edu.in

Professional Training: Post MD 26 + yrs :

Sl.No	Abroad	India
1	Osaka University-Osaka, Japan (1999,2001)	All India Institute of Medical Sciences, New Delhi (1995-2004)
2	National Institute of Biomedical Innovation-Osaka, Japan (2009, 2011)	NEIGRIHMS, Shillong (2004-2013)
3	AHCC Research Association- Sapporo, Japan (2009,2011)	Bhaba Atomic Research Center, Mumbai (1999)
4	Ion Beam Center- Hyogo, Japan (2010)	MD (Radiation Oncology): SCB Medical College, Cuttack (1991-1994)
5	ESTRO Fellowship- Arhus, Denmark (2001)	MBBS: MKCG Medical College, Berhampur (1984-1990)
6	DBT Overseas Fellowship, Govt. of India-Japan (2010)	-
7	Short term Fellowship, Erasmus University, Rotterdam, Netherlands (2017)	-
8	Holland Proton Beam Center, Delft, Netherlands (2017)	-
9	IAEA, Vienna (2018)	-
10	University of Mannheim, Germany (2018)	-
11	Short-term Fellowship on Artificial Intelligence, Wollongong University Medical Hospital, Australia (2019)	-

Professional Awards/Achievements :

MD Teacher since 2010 (AIIMS, PGIMER, JIPMER, AHPGIC, Cuttack, NIMS, Hyderabad)

External Expert, NBE

Visiting Professor, National Institute of Biomedical Innovation, Japan & Erasmus University, Netherlands

Gold Medal Oration Award, Sri Venkateshwara Medical University, Tirupati

Instrumental in setting up of 150 bedded Regional Cancer Center at NEIGRIHMS, Shillong, an autonomous institute, Govt. of India

Established Population Based Cancer Registry for the state of Meghalaya.

Established the Department of Radiation Oncology in AIIMS, Bhubaneswar and Commissioned all radiotherapy equipment.

Member, Governing Body, AH Regional Cancer Center, Cuttack.

Member, Senate, IIT, Bhubaneswar (2015-2017).

Medical Superintendent, AIIMS, Bhubaneswar (2016-2017).

Member, Board of Management, SoA University, Bhubaneswar.

Member, Board of Research, SoA University, Bhubaneswar.

Subject Expert for selection of faculty at AIIMS, Mangalagiri, AIIMS, Bhopal, CNCI, Kolkata, AHPGIC, Cuttack.

Technical Expert to National Research Development Corporation (NRDC), An Enterprise of DSIR, Ministry of Science & Technology, Govt. of India.

Technical Expert to National Development and Reform Commission for Technology Development, Validation and Commercialization (TDVC) Program for the Year 2021-22.

External Expert National Institute Ranking Framework (NIRF), MoE, GoI.

Convener, Faculty Development Program for 6 new AIIMS (2013-15).

Chairman, Examination Cell, AIIMS, Bhubaneswar (2013-2016).

Faculty In-charge, Research Cell, AIIMS, Bhubaneswar (2013-2016).

Member Grievance Redressal Cell, AIIMS, Bhubaneswar (2014-2017).

Member, Mortality Review Committee.

ESTRO Fellowship 2001.

Overseas Fellowship, Govt. of India -2010.

Member Editorial Board: Journal of Oncology & Hematology, Indian Journal of Cancer Education and Research.

Reviewer: Nine international & one national journals.

o Published 5 Book Chapters
o 112 peer reviewed articles

Most notable publication in New England Journal of Medicine in 2008 on “Tobacco Death in India”

Delivered 72 Guest Lectures.

Extramural/Multicentric Project/Trials: 04

Areas of Interest :

Brachytherapy; b) Total Skin Electron Irradiation; c) Stereotactic & Conformal radiotherapy; d) Radiation Cell Biology & Cancer Genetics

Member of Professional Bodies: 5

Survivor of Mumbai Terror Attack 2008

CURRICULUM VITAE


Name	:	Dr. Saroj Kumar Das Majumdar
Designation	:	Additional Professor
Department Affiliation	:	Radiotherapy
E-mail ID	:	radther_saroj@aiimsbhubaneswar.edu.in

Educational Qualification :

Sl.No	Degree	Year of passing	Subject	College/University
1	M.B.B.S	1993	Medicine, Surgery	S.C.B.Medical College, Cuttack/ Utkal University
2	MD	1998	Radiotherapy	S.C.B.Medical College, Cuttack/ Utkal University
3	DNB	2002	Radiotherapy	National Booard

Area of Research Interest :

Breast cancer, GI Malignancy

Head and neck Cancer, Lung Cancer

Fellowship :

UICC – ICRETT Fellowship, 2005 at MDACC USA

Honors And Awards :

Hospital based cancer Registry-data management, National Centre for Disease Informatics and Research, extramural project- funded by ICMR. (T/EM-F/Radio/17/23)

International multicenter randomized double blind phase III trial comparing safety and efficacy of BCD-021 (CJSC BIOCAD, Russia) and paclitaxel + carboplatin to Avastin® (F. Hoffmann-La Roche Ltd, Switzerland) and paclitaxel + carboplatin in inoperable or advanced non-squamous non-small-cell lung cancer (NSCLC) patients. (T/EM-F/Radth/16/04)

Prospective single arm post marketing phase IV study to assess the safety and efficacy of lenvatinib in subjects with locally recurrent or metastatic, progressive, radioiodine refractory differentiated thyroid cancer. (T/EM-F/Radio/18/03)

Efficacy and safety of IntasDenosumab in Comparison with Xgeva in patients with solid tumours with bone metastatsis. (T/EM-F/Radio/17/23)

A randomized, open- label, two periods, two treatments, two sequences, single- Dose, Crossover, Bioequivalence study of Paclitaxel Protein- bound particles for injectable suspension(albumin-bound) of Panacea Biotech, India with ABRAXANE (albumin- bound) manufactured for Celgene Corporation, Summit, NJ in patients with metastatic breast cancer under fasting conditions. (EC approval no T/EM-F/Radth/16/05)

The international multicenter double blind randomized, conducted in two phases clinical study of pharmacokinetics, efficacy and safety of BCD-022 preparation (JSC “Biocad”, Russia), as compared with the drug Herceptin) in Her 2 positive Breast cancer patients. (F.Hoffmann-La Roche Ltd.) (EC approval no T/EM-F/Radth/16/04)

An artificial intelligence approach to predict the response to chemotherapy in patients with epithelial ovarian cancer (Extramural ICMR)

Feasibility of targeted axillary dissection by tattooing the nodes with carbon: A prospective cohort study (Extramural ICMR), AIIMS/BBSR/Surgery/2019/450- Acceptance was received in March 2020.

Amulticentric open level randomized study of BC-020 (Rituximab, CJSC BIOCAD, Russia) efficacy and safety in comparision with Mab Thera/ Ristova in Monotherapy of C20 positive indolent Non-Hodgkin lymphoma. (EC approval no T/EM-F/Radth/15/10)

Membership of Professional Bodies :

Life Member “AROI”

Life member “ Indian Brachytherapy Society”

Life member of “Association UICC fellows”, Geneva, Switzerland.

Member of ASTRO

Member of ESTRO

Member of ESMO

Member of ASCO

Member of Immunology Oncology Society of India

Publications :

Majumdar S K D, Subramanian S, Biswas G, Joshi N, Khan M, Ahmad I; Efficacy and safety of nanosomal docetaxel lipid suspension-based chemotherapy in squamous cell carcinoma of head and neck- A multicenter retrospective study (2020). Oncology Letters,00:OL-22223-250411- Spandidos Publications,

Subramanian, S., Majumdar, S.K., Biswas, G., Joshi, N., Bunger, D., Khan, M.A., & Ahmad, I. (2020). Efficacy and safety of nanosomal docetaxel lipid suspension based chemotherapy in gastric and gastroesophageal junction adenocarcinoma. Molecular and Clinical Oncology, 13, 14. https://doi.org/10.3892/mco.2020.2084.

Subramanian S, Prasanna R, Biswas G, Das Majumdar SK, Joshi N, Bunger D, Khan MA, Ahmad I. Nanosomal Docetaxel Lipid Suspension-Based Chemotherapy in Breast Cancer: Results from a Multicenter Retrospective Study. Breast Cancer (DoveMedPress).(2020);12:77-85 https://doi.org/10.2147/BCTT.S236108.

Mohapatra PR, Sahoo S, Bhuniya S, Panigrahi MK, Majumdar SK, Mishra P, Patra S. Concomitant echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase rearrangement and epidermal growth factor receptor mutation in non-small cell lung cancer patients from eastern India. J Can Res Ther[Epub ahead of print,(2020 )Sept].

Mishra S, Das Majumdar SK, Sable M, Parida DK. Primary malignant mediastinal germ cell tumors: A single institutional experience. South Asian J Cancer (2020);9:27-9.

Shriwas O, Priyadarshini M, Samal SK, Rath R, Panda S, Das Majumdar SK, et al. DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG. Apoptosis Int J Program Cell Death. 25, 233–246 (2020) https://doi.org/10.1007/s10495-020-01591-8.

ShriwasO, AryaR, MohantyS, KumarS, RathR, KaushikSK, ThakurMC, FalakPahwa,DasMajumdarSK, MudulyDK, NandaRK, DashR. RRBP1 rewires cisplatin resistance in Oral Squamous Cell Carcinoma by regulating YAP-1.bioRxiv 2020.03.18.998070; doi: https://doi.org/10.1101/2020.03.18.998070.

Dhar SS, Mishra M, Kanungo S, Amritt A, Poornima Devi U,Nehla Haroon,Mohapatra B K , Pattanaik A, Sahoo B, Barik B K , Das Majumdar S K ,Parida D K . (2020) Trends of Hematological Parameters During Splenic Irradiation: A Case Report. J Blood Transfusions Dis, 3(2): 153-157.

Dhar SS, Rautray S, Das Majumdar S K, Kar A, Parida Dk etal, Papillary cystic variant of acinic cell carcinomaof parotid with preoperative diagnostic difficulty on Fine-Needle Aspiration cytology: A case Report ( http://www.ojionline.org 2020

Das Majumdar S K, Sahoo T K, Parida D K et al“Cutaneous and cardiac metastasis in carcinoma of anterior tongue” Journal of Cancer research and Therapeutics-Vol 16, Issue3, 2020

Sahoo S, Sirka CS, Das Majumdar SK, Mohapatra PR et al”Gefitinib-induced pyogenic granuloma in a patient with lung cancer”.Lung India 37(1),2020

Das Majumdar S K , Muduly D K, Mishra S ët al “Management of primary squamous cell carcinoma of the pancreas with a nanosomal paclitaxel lipid suspension-based regimen: a case report” Molecular and clinical oncology 10:430-434.2019

Sirka CS, Pradhan S, Patra S, Padhi S, Das Majumdar SK et al”Haemophagocytic lymphohistiocytosis : A rare potentially fatal complication in subcutaneous panniculitis like T-cell lymphoma”Indian Journal Of Dermatology, venereology and leprosy, 2019, 85(5), page 481-485.

Mishra S,Das Majumdar S K,Sable M N,Parida D K-Primary malignant mediastinal germ cell tumours-A single institutional experience-South Asian J Cancer 2020;9:27-9.

Maji S, Shriwas O, Samal SK, Priyadarshini M, Rath R, Panda S, Das Majumdar SK et al. STAT3- and GSK3β-mediated Mcl-1 regulation modulates TPF resistance in oral squamous cell carcinoma. Carcinogenesis. 2019 12;40(1):173–83.

Mishra S, Parida D K, Das Majumdar S K, Preetam C, Patra S- Atypical Malignancies in Head and Neck- An Experience from a Tertiary Cancer Centre of Eastern India- International Journal of Innovative Science and Research Technology Volume 4, Issue 6, June – 2019 ;366.

Mishra S, Das Majumdar S K, Kar M, Patra S, Parida D-Unusual malignancies of lung-experience from a tertiary care centre from eastern India-Abstracts, IASLC 2019 World Conference on Lung Cancer, 1041

Das Majumdar S K, Mishra S, Dhar S, Mishra P, Mohapatra S, Parida D-Prolonged survival in a case of recurrent brain metastasis-A case report-Abstracts,IASLC 2019 World Conference on Lung Cancer,1085

Occipital Neuralgia in Lung Carcinoma: A Rare Clinical Scenario Case Report, Sovan Sarang Dhar, Rajendra Sahoo, Zulfuqur Hossain Khan,Saroj Kumar Das Majumdar,Dillip Kumar Parida, Archive of Oncology 2018 Volume 24, Issue 1, Pages: 10-11

Subhasis Mishra,Ashis Patnaik,Saroj Kumar Das Majumdar,Dillip Kumar Parida, Glioblastoma Multiforme in a pediatric child: A rare Clinical Case report,Oncology Journal of India.Year 2018,Volume-2,Issue-2

Saroj K D Majumdar,Sovan S Dhar,Subhasis Mishra,Susama Patra,Sudipta Mohakud,Prasanta R Mohapatra,Dilip K Parida,, SBRT of Lung Primary After Complete Resolution of Metastatic Disease in Case of EGFR mutated Adenocarcinoma Lung: A case Report International Association For The Study of Lung Cancer[IASLC]-19th World Conference to be held at Toronto Sep 23-26,

Saroj K D Majumdar,Subhasis Mishra,Deepak K Das,Sovan S Dhar,Nabiza Begum,Saroj K Das,Susama Patra,Sudipta Mohakud,Prasanta R Mohapatra,Dillip K Parida. Metastatic Lung Carcinoma-An Institutional Experience from Eastern India

T K Sahoo, S Samal, I Dhal, S K DasMajumar, D K Parida(2017) Sertoli-leydig cell tumor of ovary, management & prognosis: a review of literature,Int Journal of scientific study, , vol 4, issue10, 164-167.

S K Das, T K Sahoo, S Parija, S K DasMajumar, D K Parida (2017) J Clinical & Diagnostic research,Choroidal metastasis as initial presentation in adenocarcinoma of lung: a case report, vol.11(3), XD04-XD06

T K Sahoo, I Dhal, S K Das, S K DasMajumar, D K Parida(2017)Synovial Sarcoma of Palmer Aspect of Hand and Survival: Arare Case Report, Journal of Clinical and Diagnostic Research 11(7): XD09-XD11.

T.K Parida, S.K. Das, S K Das Majumdar, S N Senapati, D K Parida, (2016) J Clinical & Diagnostic research ,Digital acrometastasis as initial presentation in Carcinoma Lung a case report and review of literature. vol.10(6), XD01-XD02

S Rautray, T K Sahoo, S K Das, S K Das Majumdar, D K Parida (2016) Primary adenoid cystic carcinoma of head & neck, its prognosis & management: a retrospective analysis from a tertiary care centre, Int Journal of scientific study, vol 4, issue 4, 133-137.

Saroj Kumar Das,Tapan Kumar Sahoo, Saroj Kumar Das Majumdar, Manas R Baisakh, Dillip Kumar Parida(2015) “ Primary liver Lymphoma: a case report with literature Review” Research & Reviews: journal of Oncology and hematology, 4(2),

Tapan Kumar Sahoo, Ipsita Dhal, Saroj Kumar Das Majumdar, Dillip Kumar Parida(2015) “ Primary adenocarcinoma of epiditymis, a case report and review of literature” Southeast Asian J Case Rep and Rev4(2), 1538-1543.

Tapan Kumar Sahoo, Ipsita Dhal, Ipsita Dhal, Saroj Kumar Das Majumdar, Dillip Kumar Parida , “Primary clear cell adenocarcinoma of uterine cervix in a young woman without history of diethylstilbesterol Exposure: A Case Report And Review Of Literature” Int J Sc study.2(8),198-200.

Dr. Tapan Kumar Sahoo, Ipsita Dhal, Chandra Prava Mishra, Saroj Kumar Das Majumdar, Dillip Kumar Parida , “Inflammatory Myofibroblastic Tumour Of Thigh: A Case Report And Review Of Literature” Int J Sc study.2(8),261-263.

Tapan Kumar Sahoo, Rohani Nayak, Saroj Kumar Das, Ipsita Dhal, Saroj Kumar Das Majumdar, Dillip Kumar Parida, (2014)” Carcinosarcoma of ovary and its management, a case report and review of literature” Ind J Med Case rep, 3(4), 27-30

Tapan Kumar Sahoo, Ipsita Dhal, Saroj Kumar Das Majumdar, Dillip Kumar Parida (2014) “Malignant Melanoma of Esophagus and its Prognosis: A Case Report and Review of Literature” Int J Sc Study 2(6), 151-153

Sahoo T.K., Dhal I, Das Majumdar S.K., Parida D.K.(2014) “ Synchronous Bilateral Testicular Germ Cell Tumor with Different Histology: A Case Report and Review of Literature” Int J Sci Study ;2(4):94-96

Tapan Kumar Sahoo, Manas R Baisakh, Saroj Kumar Das Majumdar, Pritinanda Mishra, Dillip Kumar Parida (2014 ) “ Small cell neuroendocrine carcinoma of prostate, a case report and review of the literature” Ind J Med Case rep3(3), 26- 29.

Sanjeev S, Durga Prasad R, Swapna LC, Jayesh K, Saroj Kumar. D. M S(2014) “ study of feasibility of portal dosimetry in comparision with Imatri XX 2-D array system for IMRT and Rapid arc patient specific QA” IOSR Journal of Engineering 4(6), 11-15.

Vijasimha M, Saroj K DM , Satyanarayan PVV, Ashok Y (2014), “ Liver type fatty acid building protein(L-FABP): Amarker of contrast induced-acute kidney injury” Advances in Life science and technology 19, 22-26.

Vijasimha M, Vijaya Padma V, Saroj K DM , Satyanarayan PVV, Ashok Y (2014), “ Kidney injury molecule-1: A urinary biomarker for contrast induced acute kidney injury ” Medical journal of Dr DY Patil University 7(3), 321-325.

Jayesh. K., Sarojkumar. D. M., Ganesh. T., Mohan. R., Rakesh. C. J., devadason S(2014) “ Influence of different parameters on optimization of IMRT patient specific QA” Trans World Medical Journal, 2(4), 187-191.

Jayesh. K., Sarojkumar. D. M., Ganesh. T., Mohan. R., Rakesh. C. J., devadason S(2014) “ validation of compass QA system and the independent verification of dose calculation algorithm for IMRT patient specific plans” Trans World Medical Journal, 2(3), 171-174.

Sahoo TK, Dhal I, Das Majumdar SK, Parida D K (2014), “Follicular Dendritic cell sarcoma and its management: A case report and review” Int J Dent Med Res 1(4): 87-89.

Vijasimha M, Vijaya Padma V, Saroj K DM , Satyanarayan PVV, Ashok Y (2013), “Evaluation of the diagnostic performance of new markers for acute kidney injury ssociated with contrast administration” journal of MGIMS 18(2), 116-121.

Mukherjee S, Raghuwansi B, Das Majumdar S K, Mohanty A P, Bhatia V ( 2013) “Platelet microparticles: origin to novel players of clinical relevance” Transworld Medical Journal, vol-1(2) 102-108.

Sirka CS, Nanda M, Majumdar SKD (2013) “ Staphylococcal sepsis presenting as oozing and bleeding from erosion: an unusual presentation” IJRRMS, vol 3(4), 41-44.

Vijasimha M, Vijaya Padma V, Saroj K DM , Satyanarayan PVV, Ashok Y (2013) “ Kidney injury molecule-1: Aurinary biomarker for contrast induced acute kidney injury”, Transworld Medical Journal 1(1) , 1-7.

Jayesh. K., Ganesh. T., Suganthi. D., Mohan. R., Rakesh. C. J., Sarojkumar. D. M. and Jacob S J. (2013) “Study of Angular Response of ImatriXX 2-D Array System and their Validation for IMRT and VMAT Patient Specific Quality Assurance”, World Academy of Science, Engineering and Technology 75, 266-267.

Jayesh. K., Ganesh. T., Suganthi. D., Mohan. R., Rakesh. C. J., Sarojkumar. D. M. and Jacob S J. (2013) “Optimization of IMRT Patient Specific QA Using Portal Dosimetry, ImatriXX 2D Array System and Point Dose Measurements”, World Academy of Science, Engineering and Technology 75, 266-267.

Jayesh. K., Ganesh. T., Suganthi. D., Mohan. R., Rakesh. C. J., Sarojkumar. D. M. and Jacob S J. (2013) “Dosimetric Comparison of aSi1000 EPID and ImatriXX 2-D Array System for Volumetric Modulated Arc and Intensity Modulated Radiotherapy Patient Specific Quality Assurance”, World Academy of Science, Engineering and Technology, 75, 263-265.

Jayesh. K., Das Majumdar. S. K., Ganesh. T., Sajeev. S.,. Madhavan. J. P., Grace Shirley. and Devadason. S. (2013) “Optimization of VMAT patient specific QA using ImatriXX 2-D array system and ionometric point dose measurements”, J.of European Society for Radiotherapy & Oncology. 106, 442.

Das Majumdar. S. K., Jayesh. K., Ganesh. T., Sajeev. S., Madhavan. J. P., Grace Shirley. and Devadason. S. (2013) “Comparison of volumetric modulated arc therapy and intensity modulated radiotherapy for pelvic malignancies” J.of European Society for Radiotherapy & Oncology. 106, 457.

Vijayasimha S, Majumdar S, Cystin C and its diagnostic ability in various clinical conditions. Indian Journal of Research and Reports in Medicak Science, vol 2, Issue 2, 2012, page 17-20.

Suresh.M, Das Majumdar.SK, Elhateer.H, Mohan.R, Shubber.M, Al-janahi.S, Naseer.AM,Jacob.J, Narayana Murthy.P. Dosimetric analysis of IMRT versus 3DCRT for Chest wall Irradiation in patients with breast cancer using 6MV X-rays, Indian Journal of Research and Reports in Medical Sciences , Volume 3, (2) July 2012 .

Moorthy S, Elhateer H, Das Majumdar S K, Shubbar, Zainab etal, Hypofractionated IMRT breast treatment with simultaneous versus sequential boost techniques . Journal of Nucl Med Radiat Ther 3: 130, 2012, 1-5. (http://dx.doi.org/10.4172/2155-9619.1000130).

Moorthy S, Murthy P N, Das Majumdar S K, Hamdy E H, Mohan R, Ramanathan V: Dosimetric characteristics of IMRT vs 3DCRT for intact breast irradiation with simultaneous integrated boost. Austral- Asian journal of cancer ISSN 0972-2556, vol 11, no-3, July 2012, 195-204.

Abdul Naseer, Mohammed; Shubbar, Sayed; George,Sara Mathew; Saroj Kumar Das Majumdar; "Primary ectopic breast cancer mimicking as vulval malignancy: A rare case report". J.Obs & Gyn Vol, 2011, 31: page 553-554.

Mohammed Abdul Naseer, Sayed Shubbar Mohammed, Sara Mathew George, Ramachandran Mohan, Saroj Kumar Das Majumdar, Mohd Abdul Basith, “Villonodular Synovitis of Left Knee joint: Role of Radiothearpy” Bahrain Medical Bulletin, June 2011,vol.33, no.2.

M.A. Naseer, S.S. Mohammed, S.K. Das Majumdar, R. Patnaik, H.M.N. Al Tublani, J.S. Justin, J.A. Meddikar: Acute respiratory distress syndrome in poor prognostic germ cell tumor with multiple lung metastases a case report: The Gulf Journal of Oncology, July 2011, issue 10, Page 69.

D.Majumdar S K, S.S.Mohammed, M.A. Naseer, J.Jacob, R. Mohan, S.B.Ebenezer, B. Al-Najar, S. Al-Janahi, V.Ramanathan, S.A. Sabt, R.S. Patnaik, A.Hassan, “Respiratory gated simultaneous integrated boost-intensity modulated radiotherapy (SIB-IMRT) after breast conservative surgery for carcinoma of the breast” Salmaniya Medical complex experience. The Gulf Journal of Oncology, July 2011, issue 10, Page 53-59.

M.A.Naseer, S.S.Muhammed, S.M.George, J.A.Meddikar, S.K.Das Majumdar, S.A.Sabt, J.S.Justin, “Gastric leiomyosarcoma: case report and review of literature” Bahrain Medical Bulletin, 2010, vol 32, no.3, page 122-124.

R. Mohan, K. Jayesh, R.C. Joshi, Maha Al- Idrisi, P.Narayanmurthy, Saroj Kumar Das Majumdar, Dosimetric evaluation of 120-leaf multileaf collimator in a Varian linear accelerator with 6MV and 18MV photon beams, Journal of Medical Physics, 2008, 33: (3) 114-118.

R. Mohan, K. Jayesh, R.C. Joshi, P.Narayanmurthy, Saroj Kumar Das Majumdar, Maha Alidrisi, Comparison of dosimetric characteristics of 120-leaf and 80-leaf multi-leaf Collimators (MLCs) in a Varian linear accelerator for a 6-MV photon beam- Radiol Phys Technol 2008,1:223-228.

Sharma D.N., Majumdar S.K.D., Mohanti B.K., Rath G.K. Profile Of deaths in Radiation Oncology Indoor Unit. The Indian Practitioner 2007; 60(7): 421-426.

Subramani V, Joshi RC, Ganesh T, Chander S, Rath GK, Gopishankar N, Dasmajumdar SK, Singh R. Dosimetric comparison of MLC leaf sequencing techniques for static and dynamic intensity modulated radiotherapy for nasopharyngeal carcinoma. IJROBP 2005; 63(1): S545-546.

Sharma R, Majumdar SKD, NandaS ,KumarS, Julka PK ,Rath GK.Alveolar Soft part Sarcoma with splenic metastsis. Indian Medical Gazette, 2005, Vol cxxxix No 4,165-169.

Sharma R, Das Majumdar SK, Nanda S, Mannan AASR, Julka PK. Primary pulmonary lymphoma with endobronchial presentation. Oncology Forum 2003; 7 (2): 5-8.

Nanda S, Sharma R, Das Majumdar S, Rath GK, Julka PK. Hormone therapy in prostate cancer : An overview. Hospital Today 2003; 5 (VIII): 223-227.

Shukla PN, Gairola M, Sharma R, Majumdar S, Lal H, Julka PK. Squamous cell carcinoma of aveolus with extensive distant metastasis: A case report. The Indian Practitioner. 2002; 1 (56): 47-49.

Nanda S, SD Majumdar, Rath GK, Bahadur S, Ray R. Leiomyosarcoma of the larynx: Case report and review of literature. Oncology Forum 2002; 4(5): 10-11.

Pathy S, Das Majumdar SK, Rath GK. Carcinoma of the Anal Canal – Current Practice and Principles of Management. Indian Medical Gazettee. 2002; 1 (XXXCI): 30-33.

Gairola M, Mishra BK, Sharma DN, Mukhopadhyay P, Das Majumdar S, Rath GK. Pancreatoblastonoma – A Case Report and Review of Literature. Indian Medical Gazette. 2001; 5 (CXXXV): 154-156.

Das Majumdar SK, Sharma R, Mishra K, Nanda S, Mathur RS, Julka PK. Adrenal metastasis from carcinoma of urinary bladder – A case report and review of literature. Indian Medical Gazette. Vol. CXXXVIII, No. 7, 2004, 313-316.

Das Majumdar SK, Naik KK, Goirala M, Umapathy H, Julka PK. Intracranial chondrosarcoma: A case report with review of literature. Indian Medical Gazette. 2002; 10 (CXXXVI): 400-402.

Majumdar SK, Gairola M, Sharma DN, Mohanti BK. Cutaneous metastasis from carcinoma of tonsil: A case report. J Post Grad Med 2002; 48: 32-33.

Das Majumdar SK, Nanda S, Gairola M, Chander S. Carcinoma cervix with endobronchial metastasis : A case report and review of literature. Oncology Forum. 2001; 1, 2 (5): 37-38.

Das Majumdar SK, Nanda S, Gairola M. Brachytherapy in lung cancer. Hospital Today. 2001; 10 (VI): 612-615.

Das Majumdar SK, Nayak KK, Sharma R, Parida DK, Julka PK. Carcinoma of bladder with vaginal and omental metastasis : An unusual occurrence. A Case report. Journal of Obstetrics, Gynaecology & Family Welfare. 2001; 29 (VII): 21-22.

CURRICULUM VITAE


Name	:	Dr. Sandip Kumar Barik
Designation	:	Assistant Professor
Department Affiliation	:	Radiotherapy
E-mail ID	:	radther_sandip@aiimsbhubaneswar.edu.in

CURRICULUM VITAE


Name	:	Dr Deepak Kumar Das
Designation	:	Assistant Professor
Department Affiliation	:	Radiotherapy
E-mail ID	:	radther_deepak@aiimsbhubaneswar.edu.in

Other Details

Clinical Activities:

a. OPD

b. IPD

c. Day Care

d. CT Simulation

e. External Radiation

f. Brachytherapy

Research Program:

a. Hospital Based cancer Registry

b. Clinical Trials

c. 05 Extramural/Collaborative projects

d. 02 intramural Projects

Community Service:

a. CEAL (Cancer Education & Learning) for the cancer patients and their family members: every Saturday

Strength:

a. Experienced faculty

b. Performing all types of External Beam Conformal Radiotherapy and Brachytherapy

c. Fully functional Day Care with 40-45 patients every working day

d. Fully Functional Brachytherapy OT

Equipment Available:

a. State-of-the-art Linear Accelerator (Versha HD) with all attachments and program for latest form of Conformal radiotherapy (external radiation)

b. 30 Channel High Dose Rate Brachytherapy (Micro-selectron) for internal radiation (Intracavitary, Intraluminal and Interstitial radiation)

c. Single Bore High Resolution CT-Simulator

Newer Conformal Radiotherapy Procedures practiced (Organ Sparing):

a. IMRT

b. VMAT

c. IGRT

d. SRS/SRT

e. SBAR/SBRT

f. Brachytherapy

g. Interventional Radiotherapy

OPD days: Mon/Wed/Fri (Registration starts at 8am) M. Special Clinics:

a. Head & Neck (with department of Otolaryngology)

b. Breast (with Surgical Oncology)

c. Paediatric (with department of paediatric oncology)

d. Neuro-oncology (with department of neurosurgery)

e. Tumor Board (with department of Surgical Oncology)

f. GI-oncology (with department of Gastroenterology & GI surgery)

Department Fees structure for various Procedures:

a. Day Care: INR 60.00

b. IPD: INR 35.00 (per day with food)

c. Radiotherapy

Sl. no	Radiotherapy procedures	For General Patients (INR)	Patients admitted to Private Ward (INR)
1	3-DCRT	750.00	3000.00
2	IMRT, IGRT	750.00	3000.00
3	SRS	75,000.00	75,000.00
4	SRT	75,000.00	75,000.00

c. All health schemes of State & Central Govt. are allowed in the department through institute.

Patient Load (last five years):

YEAR	NEW OPD	OLD OPD	DAYCARE	IPD	CT SIM	Brachy	HELA
2017	3060	9586	4107	972	-	--	-
2018	4130	12268	5256	987	259	36	3988
2019	5015	14446	6790	1070	693	132	10508
2020	3212	12257	5925	704	640	175	9294
2021	3404	17050	8700	1172	895	189	14478
2022 (Till Date)	1647	10152	5108	673	636	112	9256

Q. Vision:

To establish one Centre of Excellence for Onco-Sciences which will provide comprehensive cancer care treatment facilities under one roof to the cancer patients including cancer prevention, Genetic Cancer Clinics and Counselling, Tissue Repository, Cancer Clinical Molecular Laboratory, Bone Marrow Transplant, Particle Beam radiotherapy, Organ Preservation Surgery, Interventional Oncology, Rehabilitation of Cancer Survivors etc.

Photo Gallery

1
2
3
4
»

DEPARTMENTS

Quick Links

Radiotherapy

Radiotherapy

Medical Physicist Team

Feedback

DEPARTMENTS

Quick Links

Radiotherapy

Radiotherapy

Medical Physicist Team